AstraZeneca stock falls after FDA panel votes against new cancer drug
Shares of AstraZeneca turned lower Friday after U.S. regulatory advisors voted against approving its experimental cancer drug. An advisory panel for...
Shares of AstraZeneca turned lower Friday after U.S. regulatory advisors voted against approving its experimental cancer drug. An advisory panel for...
NEW DELHI: Leader of opposition in the Lok Sabha Rahul Gandhi on Friday launched a sharp attack on the Centre...